Wu H - Search Results

1

Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates.

Dunn CJ, Galinet LA, Wu H, Nugent RA, Schlachter ST, Staite ND, Aspar DG, Elliott GA, Essani NA, Rohloff NA, et al. Dunn CJ, et al. Among authors: wu h. J Pharmacol Exp Ther. 1993 Sep;266(3):1691-8. J Pharmacol Exp Ther. 1993. PMID: 8371167

2

Carbonyl-containing bisphosphonate esters as novel antiinflammatory and antiarthritic agents.

Nugent RA, Schlachter ST, Murphy M, Dunn CJ, Staite ND, Galinet LA, Shields SK, Wu H, Aspar DG, Richard KA. Nugent RA, et al. Among authors: wu h. J Med Chem. 1994 Dec 23;37(26):4449-54. doi: 10.1021/jm00052a004. J Med Chem. 1994. PMID: 7818726

3

Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats.

Sethy VH, Wu H, Oostveen JA, Hall ED. Sethy VH, et al. Among authors: wu h. Exp Neurol. 1996 Jul;140(1):79-83. doi: 10.1006/exnr.1996.0117. Exp Neurol. 1996. PMID: 8682182

4

The novel anxiolytic U-101017: in vitro and ex vivo binding profile and effect on cerebellar cGMP.

Sethy VH, Wu H. Sethy VH, et al. Among authors: wu h. Pharmacol Biochem Behav. 1997 Oct;58(2):609-13. doi: 10.1016/s0091-3057(97)00267-0. Pharmacol Biochem Behav. 1997. PMID: 9300626

5

Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats.

Sethy VH, Wu H, Oostveen JA, Hall ED. Sethy VH, et al. Among authors: wu h. Neurosci Lett. 1997 May 30;228(1):45-9. doi: 10.1016/s0304-3940(97)00353-4. Neurosci Lett. 1997. PMID: 9197284

6

D1 dopamine receptor activity of anti-parkinsonian drugs.

Fici GJ, Wu H, VonVoigtlander PF, Sethy VH. Fici GJ, et al. Among authors: wu h. Life Sci. 1997;60(18):1597-603. doi: 10.1016/s0024-3205(97)00126-4. Life Sci. 1997. PMID: 9126882

7

U-95666E: a potential anti-parkinsonian drug with anxiolytic activity.

Sethy VH, Ellerbrock BR, Wu H. Sethy VH, et al. Among authors: wu h. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Jul;21(5):873-83. doi: 10.1016/s0278-5846(97)00086-9. Prog Neuropsychopharmacol Biol Psychiatry. 1997. PMID: 9278957

8

Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol.

Sethy VH, Ellerbrock BR, Wu H. Sethy VH, et al. Among authors: wu h. Life Sci. 1996;58(7):585-90. doi: 10.1016/0024-3205(95)02327-5. Life Sci. 1996. PMID: 8632711

9

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

Sethy VH, Wu H, Oostveen JA, Hall ED. Sethy VH, et al. Among authors: wu h. Brain Res. 1997 Apr 18;754(1-2):181-6. doi: 10.1016/s0006-8993(97)00075-9. Brain Res. 1997. PMID: 9134974

10

D2 and D1 dopaminergic activity of 7-OH-DPAT.

Sethy VH, Ellerbrock BR, Fici GJ, Wu H. Sethy VH, et al. Among authors: wu h. Brain Res. 1996 Sep 9;733(1):41-5. doi: 10.1016/0006-8993(96)00531-8. Brain Res. 1996. PMID: 8891246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,578 results

Search Page

Filters